|
Jan 15
|
I'm Passing on Pfizer Stock in 2024. Here's Why.
|
|
Jan 14
|
Is Pfizer Stock a Buy in 2024?
|
|
Jan 13
|
7 Incredible Reasons to Buy Pfizer Stock Right Now
|
|
Jan 13
|
2 Red Flags That Could Sink Pfizer in 2024
|
|
Jan 12
|
As diversity, equity and inclusion comes under legal attack, companies quietly alter their programs
|
|
Jan 12
|
Pharma Stock Roundup: MRK to Buy Harpoon, JNJ to Acquire Ambrx Biopharma & More
|
|
Jan 11
|
UPDATE 1-Weight loss drug windfall attracts pharma companies
|
|
Jan 11
|
Drugmakers plot way into obesity market with deals and development
|
|
Jan 11
|
A Bull Market Is Coming: 2 Magnificent Stocks Down More Than 50% to Buy Right Now
|
|
Jan 10
|
Pfizer Recommends Shareholders Reject the Below-Market Mini-Tender Offer by TRC Capital Investment Corporation
|
|
Jan 10
|
JPM's annual healthcare conference: Here's what's next for GLP-1s and the weight loss market
|
|
Jan 10
|
UPDATE 1-US FDA allows import of syphilis drug to address shortages
|
|
Jan 9
|
Here's Why Pfizer (PFE) Fell More Than Broader Market
|
|
Jan 9
|
2024 Marks a New Era Of Pharmaceutical Innovation
|
|
Jan 9
|
Ambrx (AMAM) Skyrockets 102% on $2B Buyout Offer From J&J
|
|
Jan 9
|
JPM24: Pfizer’s tough sell, the next Karuna and building a biotech platform
|
|
Jan 9
|
MercadoLibre and Pfizer have been highlighted as Zacks Bull and Bear of the Day
|
|
Jan 9
|
UPDATE 2-BioNTech predicts return to revenue growth in 2025
|
|
Jan 2
|
Moderna Stock Starts 2024 With an Upgrade After a Terrible Year. Here’s Why.
|
|
Jan 2
|
10 clinical trials to watch in the first half of 2024
|